These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19641491)

  • 1. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.
    Pizzi C; Mancini S; Angeloni L; Fontana F; Manzoli L; Costa GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):527-32. PubMed ID: 19641491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.
    Bot M; Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Mann DL
    J Psychosom Res; 2011 Jul; 71(1):13-7. PubMed ID: 21665007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C; Lynch G; King DJ; Cooper SJ
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
    Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
    Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
    Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH
    J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics.
    Roy A
    Biol Psychiatry; 1998 Oct; 44(7):633-7. PubMed ID: 9787889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
    Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
    Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
    Michalakeas CA; Parissis JT; Douzenis A; Nikolaou M; Varounis C; Andreadou I; Antonellos N; Markantonis-Kiroudis S; Paraskevaidis I; Ikonomidis I; Lykouras E; Kremastinos D
    J Card Fail; 2011 Sep; 17(9):748-54. PubMed ID: 21872145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
    Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
    Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.
    Taraz M; Khatami MR; Dashti-Khavidaki S; Akhonzadeh S; Noorbala AA; Ghaeli P; Taraz S
    Int Immunopharmacol; 2013 Nov; 17(3):917-23. PubMed ID: 24121064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
    Serebruany VL; Suckow RF; Cooper TB; O'Connor CM; Malinin AI; Krishnan KR; van Zyl LT; Lekht V; Glassman AH;
    Am J Psychiatry; 2005 Jun; 162(6):1165-70. PubMed ID: 15932816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial.
    Sherwood A; Blumenthal JA; Smith PJ; Watkins LL; Hoffman BM; Hinderliter AL
    Psychosom Med; 2016 Jun; 78(5):602-9. PubMed ID: 26867076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
    Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin.
    Varia I; Logue E; O'connor C; Newby K; Wagner HR; Davenport C; Rathey K; Krishnan KR
    Am Heart J; 2000 Sep; 140(3):367-72. PubMed ID: 10966532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.
    McFarlane A; Kamath MV; Fallen EL; Malcolm V; Cherian F; Norman G
    Am Heart J; 2001 Oct; 142(4):617-23. PubMed ID: 11579351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
    Ghobadian A; Mokhtari S; Shariati B; Kamalzadeh L; Shati M; Eftekhar Ardebili M; Yarahmadi M; Shalbafan M
    BMC Pharmacol Toxicol; 2022 Sep; 23(1):73. PubMed ID: 36167636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.